Exploring Deep Brain Stimulation for Treatment-resistant Tinnitus: A Comprehensive Review

Subachhanda Behuriya^*
*Correspondence: Subachhanda Behuriya, Department of Neurosurgery, University Hospital of Lausanne, 1011 Lausanne, Switzerland, Email:

Keywords

Tinnitus • Deep brain stimulation • Neuromodulation • Auditory pathway

Introduction

Tinnitus, the perception of sound in the absence of external stimuli, is a common auditory disorder affecting millions of individuals worldwide. It can manifest as ringing, buzzing, hissing, or other phantom sounds and can significantly impact quality of life, leading to sleep disturbances, anxiety, depression and impaired concentration. While various treatment modalities, including pharmacotherapy, sound therapy and cognitive behavioral therapy, have been explored for tinnitus management, a significant proportion of patients remain refractory to conventional therapies. This treatment-resistant population represents a challenging clinical cohort with limited therapeutic options and underscores the need for alternative approaches to tinnitus management. Deep Brain Stimulation (DBS), a neuromodulation technique that involves the delivery of electrical impulses to specific brain regions via implanted electrodes, has garnered increasing interest as a potential therapeutic option for treatment-resistant tinnitus. DBS has been widely used for the treatment of movement disorders such as Parkinson's disease and essential tremor and has shown promising results in modulating neural activity and circuitry within the central nervous system. In recent years, there has been growing interest in exploring the utility of DBS for tinnitus management, leveraging its ability to modulate aberrant neural activity and restore auditory processing within the central auditory pathway [1].

Literature Review

The exploration of DBS for the treatment of tinnitus builds upon a growing body of preclinical and clinical evidence elucidating the neural mechanisms underlying tinnitus pathophysiology. Animal studies have provided valuable insights into the neuroanatomical and neurochemical changes associated with tinnitus, highlighting the involvement of various brain regions, including the auditory cortex, thalamus and limbic system, in the generation and maintenance of tinnitus-related neural activity. Furthermore, neuroimaging studies in humans have revealed alterations in functional connectivity and neural synchronization within the central auditory pathway in individuals with tinnitus, implicating maladaptive neuroplasticity as a key contributor to tinnitus perception and severity. The rationale for using DBS for tinnitus stems from its ability to modulate neural activity within targeted brain regions implicated in tinnitus pathophysiology. Preclinical studies utilizing animal models of tinnitus have demonstrated the efficacy of DBS in attenuating tinnitus-related neural hyperactivity and restoring auditory processing in the central auditory pathway. For example, DBS of the auditory cortex or thalamus has been shown to suppress tinnitus-like behavior and normalize neuronal firing patterns in animal models, suggesting its potential as a therapeutic intervention for tinnitus. Building upon preclinical evidence, clinical studies have begun to investigate the safety and efficacy of DBS for tinnitus in human subjects. Initial case reports and small-scale clinical trials have shown promising results, with some patients experiencing significant reductions in tinnitus severity and distress following DBS treatment. For instance, DBS of the auditory cortex or thalamus has been associated with improvements in tinnitus loudness, frequency and intrusiveness in select patients with treatment-resistant tinnitus. Moreover, neuroimaging studies have revealed changes in brain activity and connectivity patterns following DBS treatment, providing insights into the neural mechanisms underlying its therapeutic effects [2,3].

Discussion

The discussion section of a review on Deep Brain Stimulation (DBS) for treatment-resistant tinnitus encompasses an analysis and interpretation of the findings presented in the literature review. It provides insights into the implications of the evidence, discusses the limitations and challenges of DBS as a therapeutic intervention for tinnitus and outlines future research directions. Below is an outline of potential discussion points:

Clinical effectiveness: Evaluate the clinical effectiveness of DBS for tinnitus based on the available evidence. Discuss the degree of tinnitus relief achieved in clinical trials and case reports, considering factors such as changes in tinnitus severity, loudness and distress. Highlight any trends or patterns observed in patient outcomes, including variability in treatment response and factors influencing treatment success.

Mechanisms of action: Explore the underlying mechanisms through which DBS modulates neural activity within the central auditory pathway and influences tinnitus perception. Discuss preclinical studies that have investigated the neurobiological effects of DBS on tinnitus-related neural hyperactivity, synaptic plasticity and neurotransmitter release. Consider how DBS may interact with aberrant neuroplastic changes in the auditory system and restore balance to dysfunctional neural circuits [4].

Neuroanatomical targets: Evaluate the choice of neuroanatomical targets for DBS in the treatment of tinnitus. Discuss the rationale behind targeting specific brain regions implicated in tinnitus pathophysiology, such as the auditory cortex, thalamus and limbic system. Consider the advantages and limitations of targeting different brain structures and their potential impact on treatment outcomes.

Stimulation parameters: Analyze the impact of stimulation parameters, including electrode placement, frequency, amplitude and pulse width, on the efficacy of DBS for tinnitus. Discuss the optimal stimulation parameters identified in clinical trials and their effects on tinnitus perception and severity. Consider individual variability in stimulation response and the importance of personalized treatment approaches [5].

Safety and adverse effects: Assess the safety profile of DBS for tinnitus, including the incidence and severity of adverse effects associated with DBS surgery and stimulation. Discuss common adverse effects such as surgical complications, hardware malfunction and stimulation-related side effects such as paresthesia, vertigo, or cognitive changes. Consider strategies for minimizing adverse effects and optimizing patient safety during DBS treatment.

Patient selection and clinical guidelines: Discuss the criteria for patient selection and candidacy for DBS in the treatment of tinnitus. Consider factors such as tinnitus severity, duration, impact on quality of life and response to previous treatments. Evaluate existing clinical guidelines and consensus statements on the use of DBS for tinnitus and their implications for clinical practice.

Future directions: Outline future research directions and priorities in the field of DBS for tinnitus. Discuss the need for large-scale, multicenter clinical trials to further evaluate the safety, efficacy and long-term outcomes of DBS treatment. Consider the potential for advancements in neuroimaging techniques, biomarker discovery and personalized medicine to enhance patient selection and optimize treatment outcomes. Highlight emerging technologies and novel approaches for neuromodulation, such as closed-loop stimulation and noninvasive brain stimulation techniques and their potential applications in the treatment of tinnitus.

Integration with multimodal therapies: Explore the potential role of DBS as part of multimodal treatment approaches for tinnitus. Discuss how DBS could be integrated with existing therapeutic modalities, including sound therapy, cognitive behavioral therapy and pharmacotherapy, to optimize treatment outcomes and address the multidimensional nature of tinnitus. Consider the synergistic effects of combining DBS with complementary interventions and the potential for enhanced symptom relief and patient satisfaction [6].

Conclusion

In conclusion, the exploration of DBS for the treatment of treatment-resistant tinnitus represents a promising avenue for addressing the unmet needs of patients with chronic tinnitus. Building upon preclinical and clinical evidence, future research efforts should focus on elucidating the underlying mechanisms of DBS-mediated neuromodulation, optimizing stimulation parameters and identifying biomarkers predictive of treatment response. Through collaborative efforts between researchers, clinicians and industry stakeholders, DBS holds the potential to revolutionize tinnitus management and improve outcomes for patients with this debilitating auditory disorder.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Tunkel, David E., Carol A. Bauer, Gordon H. Sun and Richard M. Rosenfeld, et al. "Clinical practice guideline: Tinnitus." Otolaryngol Head Neck Surg 151 (2014): S1-S40.

Google Scholar, Crossref, Indexed at

2. Bhatt, Jay M., Neil Bhattacharyya and Harrison W. Lin. "Relationships between tinnitus and the prevalence of anxiety and depression." Laryngoscope 127 (2017): 466-469.

Google Scholar, Crossref, Indexed at

3. Maes, Iris HL, Rilana FF Cima, Johannes W. Vlaeyen and Lucien JC Anteunis, et al. "Tinnitus: A cost study." Ear Hear 34 (2013): 508-514.

Google Scholar, Crossref, Indexed at

4. Stockdale, David, Don McFerran, Peter Brazier and Clive Pritchard, et al. "An economic evaluation of the healthcare cost of tinnitus management in the UK." BMC Health Serv Res 17 (2017): 1-9.

Google Scholar, Crossref, Indexed at

5. Jarach, Carlotta M., Alessandra Lugo, Marco Scala and Piet A. van den Brandt, et al. "Global prevalence and incidence of tinnitus: A systematic review and meta-analysis." JAMA Neurol 79 (2022): 888-900.

Google Scholar, Crossref, Indexed at

6. Wang, Kunkun, Dongmei Tang, Jiaoyao Ma and Shan Sun. "Auditory neural plasticity in tinnitus mechanisms and management." Neural Plast 2020 (2020).

Google Scholar, Crossref, Indexed at